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Background: New technologies have recently been used for monitoring signs and symptoms of mental health
illnesses and particularly have been tested to improve the outcomes in bipolar disorders. Web-based psychoeducational
programs for bipolar disorders have also been implemented, yet to our knowledge, none of them have integrated both
approaches in one single intervention. The aim of this project is to develop and validate a smartphone application to
monitor symptoms and signs and empower the self-management of bipolar disorder, offering customized embedded
psychoeducation contents, in order to identify early symptoms and prevent relapses and hospitalizations.
Methods/design: The project will be carried out in three complementary phases, which will include a feasibility study
(first phase), a qualitative study (second phase) and a randomized controlled trial (third phase) comparing the
smartphone application (SIMPLe) on top of treatment as usual with treatment as usual alone. During the first phase,
feasibility and satisfaction will be assessed with the application usage log data and with an electronic survey. Focus
groups will be conducted and technical improvements will be incorporated at the second phase. Finally, at the third
phase, survival analysis with multivariate data analysis will be performed and relationships between socio-demographic,
clinical variables and assessments scores with relapses in each group will be explored.
Discussion: This project could result in a highly available, user-friendly and not costly monitoring and
psychoeducational intervention that could improve the outcome of people suffering from bipolar disorders in a
practical and secure way.
Trial registration: Clinical Trials.gov: NCT02258711 (October 2014).
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Bipolar disorder is a frequent condition in the general
population with a high morbimortality [1]. It is character-
ized by dysfunctional episodic fluctuations between differ-
ent mood phases ranging from depression to manic
episodes with patients presenting frequent interepisodic
subsyndromal symptoms. Frequently, people with this* Correspondence: evieta@clinic.ub.es
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article, unless otherwise stated.condition have a lack of insight about their diagnosis and
symptoms, especially regarding manic phases, which leads
to poor prognosis [2,3].
Besides the pharmacological treatment, adjunctive psy-
chological interventions have shown to improve the long-
term outcome of the disorder [4], although, taking into
account the limited resources currently available, their ex-
tended implementation is still difficult and costly [5].
Among psychotherapeutic interventions, psychoeduca-
tional programs have proven to be cost-effective in helping
patients recognize early signs or symptoms and adopt be-
havioral measures to prevent full-blown episodes whichCentral. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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hospital admissions [6,7]. Accordingly, there is an in-
creased need to make this intervention more widely avail-
able, without compromising its quality [4].
On the other hand, the wide use and availability of
new technologies such as the Internet have been suc-
cessfully adopted in mental health contexts. Using these
technologies in patient’s assessments and interventions
have proved their efficacy and reliability as well as their
good acceptability from the patient’s perspective [8,9].
The potential improvement in accessibility to healthcare
in patients with disabilities or patients living in rural or
other remote areas (i.e. telemental health), as well as the
lower costs when compared to conventional interven-
tions, makes them an attractive complement to standard
treatment [10-13].
Furthermore, the progressively reduced costs and con-
sequent widespread accessibility to mobile phones with
internet connection (smartphones) opens an unlimited
number of opportunities to the mental health field. In
industrialized countries, these devices have become a
very popular way of interacting with each other and with
the environment. As an example, in Spain, a recent
study of the National Institute of Statistics revealed that
almost 70% of the population have internet access and
in the majority, through a mobile device [14]. This is a
growing phenomenon and includes developing countries
as well. According to eMarketer Inc., a company which
studies technology market trends, by 2017 one-third of
all the population around the globe will be using a
smartphone [15].
In addition, the constant improvement of portability and
benefits of mobile devices allows the quick and continuous
collection of relevant users’ information at a low-cost.
Data on subject’s activity and interests, through embedded
sensors and mobile usage patterns respectively, are col-
lected and complemented with information from other
digital services such as social networks, e-mails and inter-
net search patterns. All this information that has been
denominated “big data” are integrated, analyzed by data
mining and results are used to determine individual user
behavior and interests patterns by predictive analytics,
which now are commonly used for commercial purposes
[16]. Accordingly, there is an increasing interest in medi-
cine and especially in mental health to explore the
possibilities and potential applications of this underutilized
data [17-20].
The potential of the great amount of data collected by
the patient’s smartphones, its analysis and potential ap-
plications in treatment interventions are leading the way
to the (so-called) “Personalized Medicine” era. Given the
diverse types of presentations, course and response to
treatments in mental disorders, including new technolo-
gies has long been promoted as the obligatory next stepin different medical disciplines, and especially in psych-
iatry [21-24]. However, one major concern about this ap-
proach is the potential threats to patient’s privacy and
consequent utilization of this data with others intends, if
it is transmitted, processed or stored insecurely [25,26].
Several projects have tested the benefits of these new
technologies for the treatment of bipolar and psychotic
disorders using either online monitoring of signs and
symptoms [27,28] or web-based psychoeducational pro-
grams [29-32], yet to our knowledge, none of them have
integrated both approaches in one single intervention.
The current technology available makes technically eas-
ier to integrate into patient’s life a comfortable, simple,
time-unconstrained, user-friendly, economical and non-
invasive method of registering and monitoring relevant
signs and symptoms and provide continuous self-
management psychoeducational contents tailored to the
specific needs of each individual on the basis of these data
registered on their own smartphones [33]. Additionally,
this approach could contribute to better understand the
pathoetiology as well as prodromal behavior patterns prior
to a relapse in bipolar disorders, integrating objective and
subjective data with other clinical correlates [17].
We hypothesized that, combining a signs and symptoms
monitoring system with continuous feeds of tailored psy-
choeducational in a single smartphone application as an
adjunctive intervention to usual treatment, would add effi-
cacy in preventing relapses, suicide attempts and health
resources consumption in bipolar patients improving their
overall prognosis.
The aim of this study is to develop and clinically validate
a smartphone application to monitor symptoms and signs
in bipolar patients, offering customized embedded psy-
choeducation contents and empower the self-management
of their disorder in order to prevent relapses and hospitali-
zations. Secondary objectives are to explore other clinical
benefits among the smartphone application users such as
improvements in biological rhythms, manic/hypomanic
and depressive symptoms, quality of life, suicide attempts
and pharmacological treatment adherence.
Methods and design
Given the incipient nature of the field, we adopted an
eclectic approach considering and combining multiple
guidelines and recommendations about developing inter-
net and mobile interventions for mental health [34-36].
In order to consider technical aspects and an adequate
clinical validation while including patients preferences
and safety along the process, it was determined that the
project will be carried out in three complementary
phases, which will include two clinical studies. The stud-
ies will follow the Consolidated Standards of Reporting
Trials (CONSORT) guidelines to describe, report and
publish the results [37] (Figure 1).
Figure 1 The figure shows a flowchart of the SIMPLe project
phases (left) and their expected duration (right). *Current status
of the study. TAU = Treatment as usual.
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During one year (May 2013 to May 2014) a collaborative
team of specialists in bipolar disorder (psychiatrists and
psychologists from the Bipolar Disorders Program of the
Hospital Clínic of Barcelona) and software engineers as
well as graphical designers held periodical meetings in
order to determine the design of an online tool to monitor
and register signs and symptoms of bipolar disorder and
offer personalized psychoeducation contents. At the end of
this process, the team resolved to develop a smartphone
application with the following characteristics: user-friendly,
non-stigmatizing and sensitive enough to detect mood
changes in order to give customized psychoeducational
feedback based on an existing psychoeducation group
treatment manual [38], which has been previously tested by
the Barcelona Bipolar Disorders Program [6].
Several evidence-based methods for self-mood assess-
ment were considered taking into account the aims of the
project. We chose 5 daily key questions balancing sensitiv-
ity and privacy, which are intended to be answered in a
few seconds with the aid of an animated graphical inter-
face (i.e. mood, energy, sleep time, irritability and medica-
tion adherence). If a relevant mood change is detected by
means of an algorithm that takes into consideration the
previous week mean score of the daily test, the user is re-
quested to answer a more comprehensive second test
based on the DSM-5 [39] criteria for mania, hypomania or
depression, along with some extra questions regarding
substance use and suicide risk. If the patient gives an af-
firmative answer to the question that explores suicidal
ideation, an automatic e-mail message is sent to the men-
tal healthcare team and in addition, an immediate call to
emergency services is offered. Otherwise, if the subject is
stable during their daily assessments, this DSM5 based test
is requested to be answered only once a week.
Furthermore, the application will give feedback with a
graphic showing daily mood changes and the user will be
able to review the results of previous tests. Personalized daily
psychoeducative messages will be sent based on the patient’s
answers. The user will be able to customize the best time of
the day to answer the test and to receive the psychoeducative
messages at his or her convenience (Figure 2).
Simultaneously, a web-based interface will be devel-
oped to allow the mental healthcare team to follow and
monitor patient status.
The collaborative team decided that it was necessary a
first study to determine the acceptability and validity of
an application based solely on subjective information
(SIMPLE 1.0), prior to the addition of objective monitoring
data modules (SIMPLE 2.0) for three reasons: 1. In order to
give patients active participation in the development of the
application through focus groups and satisfaction surveys
based on the experience with the first SIMPLE version and
adapt the application to their preferences; 2. To test data
Figure 2 The chart shows the way in which the application SIMPLe 1.0 gives psychoeducative messages based on the answers of daily
and weekly tests.
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To adjust possible mood sensitivity issues with the daily
and weekly questionnaires which were not previously vali-
dated in a real-world clinical setting (Figure 3).
Study design and phases
The studies to evaluate the smartphone application will be
carried out in three different but complementary phases as
detailed below.
 First phase: A three months lasting feasibility study
will be conducted in order to evaluate the use,
reliability and patient satisfaction with symptom
monitoring (subjective information). Patients under
usual treatment will use a smartphone with the
SIMPLe version 1.0 application installed. The
intervention will be consecutively offered to 30
stable adults (>18 years) fulfilling the inclusion
criteria described below. An informed consent will
be handled and explained and must be signed in
order to participate. Sociodemographic data and
standardized clinical as well as functional
assessments will be administered at baseline andmonthly for three months. Assessments will include
present manic symptoms using the Young Mania
Rating Scale (YMRS) [40,41], depressive symptoms
using the Hamilton depression Rating Scale (HDRS)
[42,43], biological rhythms using the biological
rhythms interview of assessment in neuropsychiatry
(BRIAN) [44,45] and treatment adherence using the
Morisky Green 8-item test [46]. A smartphone de-
vice with the SIMPLe 1.0 application pre-installed,
will be given to the participants for free during the
study with the mandatory condition that it has to be
their main mobile-phone during the next 3 months.
In the case the patient accepts to participate but
doesn’t want to switch from his/her current smart-
phone, he/she will be offered the possibility to
download the SIMPLe 1.0 application from the Ap-
plication Store and a username and password will be
given. The subject will receive a customizable auto-
matic reminder in their smartphone to answer both
daily and weekly questionnaires based on DSM-5
criteria for a manic, hypomanic, mixed or depressive
episodes. The data obtained will be registered online.
During this period of time, the subjects will receive
Splash screen             Mood review chart Daily test screen Weekly test screen
Figure 3 Screenshots of SIMPLe 1.0 running in an Android Smartphone.
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on the information collected by the application using
an algorithm designed by our team. Feasibility and
satisfaction will be assessed with the application
usage log data and with an electronic survey.
Reliability will be analyzed comparing the clinical
assessments made by a psychiatrist and the informa-
tion about mood state collected by the application
 Second phase: Three different focus groups
(patients, psychiatrists and psychologists, software
engineers and graphical designers) of 3 sessions each
will be held to discuss the experience with the
SIMPLE 1.0 app and recollect suggestions and bugs.
Additionally, individual personal interviews with
each SIMPLE 1.0 user will also collect qualitative
information about the application and suggestions.
Taking into consideration the information collected
from participants in the first phase, the application
will be adapted and improved with the addition of
objective information (signs) monitoring modules
using mobile usage parameters and the built-in
actimetry sensors.
 Third phase: A six months randomized controlled
trial with an intervention and a control arm
including 74 patients each. An initial evaluation in
both groups will be carried out recollecting
sociodemographic data and using standardized
clinical as well as functional assessments. This
evaluation will be repeated at three, six and twelve
months from baseline. The assessments will include
present manic symptoms using the Young Mania
Rating Scale (YMRS), depressive symptoms using
the Hamilton depression Rating Scale (HDRS),
functional impairment using the Functioning
assessment short test (FAST) [47], biological
rhythms using the biological rhythms interview ofassessment in neuropsychiatry (BRIAN), quality of
life measured by World Health Organization quality
of life assessment (WHOQOL-BREF) [48] and
treatment adherence using the Morisky Green
8-item test. During the follow-up the number of
relapses, inpatient admissions, outpatient consultations,
emergency rooms consultations and suicide attempts
will be registered.
1. Intervention arm (SIMPLe 2.0 + TAU): The
experimental group will use the application SIMPLe
2.0 and will keep receiving their usual
pharmacological treatment. A smartphone device
with the SIMPLe 2.0 application pre-installed, will
be given to the participants for free during the study
with the mandatory condition that it has to be their
main mobile-phone during the next 3 months. In
the case the patient accepts to participate but does
not want to switch from their current smartphone,
they will be offered the possibility to download the
SIMPLe 2.0 application from the Application Store
and a username and password will be assigned. The
self-mood assessments will adopt a similar approach
to the SIMPLe 1.0 app. Additionally this information
will be complemented with automatically recorded
patients activity data which will include smartphone
usage, telephone calls made (number of independent
calls and total time), social network apps usage, and
physical activity measured by the built-in actimeter.
Patients will receive daily psychoeducative messages
based on the data recollected by the application.
Relapse risk will be calculated using an algorithm in-
cluding both subjective and objective data. The clinical
team will be contacted with an e-mail if there is mod-
erate or high risk for an oncoming episode and the
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for assistance.
2. Treatment as usual arm (TAU): The treatment as
usual (TAU) group will be followed-up with their
standard treatment following the Barcelona Bipolar
Disorders Program protocol [49].
Participants
Sample recruitment
The participation in the study will be offered to stable
bipolar patients (YMRS ≤ 8, HDRS ≤ 6 for at least one
month prior to study entry) who had experienced at
least one hypomanic, manic or depressive relapse during
the 12 months prior to the study entry. All the partici-
pants will be adult patients attending the outpatient
mental health clinic of the Hospital Clinic of Barcelona.
All participants in both groups must read and agree with
the terms and sign an informed consent prior to their
inclusion in the study.
The following selection criteria will be considered for
the first and third phase:
Inclusion criteria
1. Age from 18 to 65 years old, 2. Patients with a current
diagnosis of Bipolar disorder type I or type II according
to DSM-5 criteria and confirmed with a semi-structured
interview (SCID), 3. Hamilton Depression Scale score
under or equal to 8 during the last month, 4. Young
Mania Rating Scale score under or equal to 6 during the
last month, 5. No history of relapses during the previous
3 months but at least 1 relapse during the last year, and
6. Availability of an unlimited smartphone data plan dur-
ing the 12 following months to avoid extra costs for the
participants when using the application.
Exclusion criteria
1. Lack of skills to use the offered smartphone or unwill-
ingness to learn them, 2. FAST score above or equal to 20,
3. Current or recent (within the last four years) participa-
tion in psychoeducation groups or in individual psycho-
logical treatment for the management of bipolar disorder
that includes psychoeducational interventions, 4. Obses-
sive-compulsive disorder according to DSM-5 criteria, 5.
Concomitant severe medical condition, 6. Current
pharmacological treatment with long-acting antipsychotics
and 7. Pregnancy.
Randomization, data anonymization and blinding
A 5 digits random identification number (IDN) will be
generated for all the participants throughout all the phases
of the study. The cross-reference of this identification
number and the patient identity will be encrypted and
stored in a database file. Those patients using the smart-
phone application will be identified only by the IDN,which will be also the username to access the application.
The patient will be asked by the application to enter the
username and a password once per smartphone session if
he/she is using a current security method to block the
phone (code, pattern, face or finger recognition), otherwise
the user will have to enter the username and password
every time the SIMPLE app is opened.
During the third phase, an independent researcher using
the site randomizer.org [50] will randomize the sample to
the intervention group or to the control group. Interviews,
assessments and focus groups related to the study will be
carried out by independent clinicians. Due to ethical con-
siderations, this blinding process will be interrupted if a
risk situation is detected through the application during
any phase of the study. In this case, the subject will be
identified and their therapists will be informed immedi-
ately. Exclusion from the study will be discussed depend-
ing on the circumstances.
Power and sample calculation
We adopted a conservative approach for the first phase of
the study to ensure more close qualitative feedback.
Accordingly we calculated a sample size of 30 based in the
recommendations for internal pilot studies from Kieser&-
Friede [51]. For the third phase, a significance level of
0.05, power of 0.8 and a minimal detectable difference of
0.5 and an expected drop-out of 15% was set, which
resulted according to the design in two arms of 74 patients
each [52].
Statistical analysis
During the first phase, a descriptive analysis of socio-
demographic and clinical variables will be conducted,
including mean age, sex, marital status, employment sta-
tus, family psychiatric history, follow up time, number of
episodes, predominant polarity, substance abuse and
comorbid medical and psychiatric diagnoses. Feasibility
will be evaluated analyzing the frequency of daily and
weekly tests completed, if important differences in base-
line characteristics between adherent and not adherent
users are detected, this will be further controlled by re-
gression analyses. The results of the satisfaction survey
will be estimated analyzing the percentage of answers
and the differences among the different categories using
Chi-square analysis. Additionally, a Pearson correlation
analysis will be carried out between the results of the
assessments during the 3 month period and the results
of the application tests to evaluate the clinical reliability
between the two methods.
At the third phase, survival analysis with multivariate
data analysis will be carried out to assess several covariates
simultaneously and explore relationships between socio-
demographic, clinical variables and assessments scores
with relapses in each group (Kaplan-Meier). Similarly,
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lyzed with multivariate survival analysis (Cox regression).
Similarly as in the first phase, a Pearson correlation analysis
will be carried out between the results of the assessments
and completed application tests. All the analyses will be
two-tailed with an alpha set at p < 0.05. Additionally, last
observation carried-forward intention to treat analyses will
be performed.
Ethical and safety considerations
One of the main concerns during the development of
the application was patient safety. Hence, the application
incorporated a function which automatically notify the
mental health team about suicide risk and give the
patients the possibility to make a call to the emergency
services from their own smartphone. Depending on the
severity of the symptoms or if suicidal risk is detected, the
blinding of the protocol will be broken and the case will
be immediately discussed with their therapists.
In order to ensure participants’ confidentiality during
the study and the transmission of personal data we
adopted a security protocol using the IDN, as it has been
previously described, which is in accordance to the local
spanish laws (Ley orgánica de Protección de Datos de
Carácter Personal (15/1999)). The username and pass-
word for the application will be requested every time the
application is used if the user didn’t active a smartphone
lock system, otherwise it could be used without entering
the username and password. Additionally, the study proto-
col was evaluated and approved (Reg. HCB/2014/0403) by
the Hospital Clinic of Barcelona ethical committee to en-
sure is accordance to the Helsinki Declaration. The study
was registered at Clinicaltrials.gov with the identifier
NCT02258711 on October 2014.
Trial status
At the time of the elaboration of this manuscript the
development phase of SIMPLe 1.0 was concluded and a
testing process of the application was being carried out
intensively by 4 software engineers, 7 psychologists and 7
psychiatrists before the initiation of the first phase of the
study with patients.
Discussion
Even when the current pharmacological and psychological
treatments available for bipolar disorder can certainly im-
prove the outcome and quality of life of bipolar patients,
the access to such specialized treatments are concentrated
in few reference centers around the globe, which can
hardly cover the needs of a disease with a prevalence of
almost 2% of the world population [53].
On the other side, during recent years new technolo-
gies have facilitated our life in many ways (e.g. internet
shopping, traveling and communication), although itsimplementation in mental healthcare has been slow
and underdeveloped when compared to other areas
(i.e. commercial). Hence, using this technology in men-
tal healthcare could improve the lives of thousands of
people suffering from mental disorders at a very low
cost and in a convenient, comfortable and secure way
for patients.
Among other treatments, our research group has been
promoting and providing high-quality evidence-based psy-
choeducational programs for more than 15 years [54,55].
However, our current face-to-face approach to psychoedu-
cation excludes many patients who could benefit from it,
such as those living in remote locations, those with incom-
patible schedules, patients who don’t want to attend a
group therapy, etc. One of the advantages of new technolo-
gies, and specifically smartphones, is that it is possible to
overcome these difficulties in a cost-efficient way through
them. The tested application will represent a user-friendly,
low cost and a potentially efficacious way to provide self-
monitoring and personalized training to bipolar patients
as an add-on to usual pharmacological and psychological
care. Another benefit of this device is to include measures
to facilitate safety procedures if any risk (i.e. suicidal
thoughts) is detected. Furthermore, it can have a positive
impact on associated healthcare costs.
There are some potential risks and limitations of this
project: The fact that the patient will interact with a device
instead of a therapist could decrease the level of comprom-
ise with the program. Furthermore, despite the fact that
most people can have access to smartphones there is still a
requirement of a minimum range of skills to use this kind
of devices and operating systems. In this regard, many pa-
tients with bipolar disorder have some degree of cognitive
or functional impairment [56], which could limit their cap-
acity to use the device. In fact, a recent study has proven
that patients with bipolar disorder show a poorer know-
ledge of computer use devices, internet and social media
when compared with matched healthy controls [57].
Regarding the limitations of the study itself, the inter-
vention is compared to treatment as usual and patients
are not blinded to the intervention that they are receiv-
ing. It is almost impossible to create a “placebo smart-
phone application”. Another fact is that all participants
will be recruited from a specialized mental healthcare cen-
ter in bipolar disorder, which could limit the generalizability
of the results to primary care contexts due to the clinical
characteristics of the sample and the intensive healthcare
character of the program.
If the first steps of the project show encouraging
results, many of the mentioned limitations could be
circumvented in the future including active comparators
such as conventional psychoeducational programs and
involving non-specialized settings in future efficiency
studies.
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